The Pittsburgh Breast Cancer Consortium
Annual rept. 1 Aug 2001-31 Jul 2002
PITTSBURGH UNIV PA
Pagination or Media Count:
The specific aims of this proposal are 1 to develop a breast cancer clinical trials infrastructure to allow the rapid phase I and phase II development of novel agents for the treatment of breast cancer with a strong emphasis on community-based practice involvement and 2 to evaluate multiple agents, as well as combinations of agents, using this infrastructure. In this progress report, we will detail how our objectives to date have been met. The workstatement will be used as a template. To briefly summarize, we have established the infrastructure of the PBCC and are currently conducting clinical trials of novel agents and combinations of agents. As noted in the original proposal, priorities of industrial sponsors change, as do the availability of agents. While we have not conducted all of the proposed clinical trials, other trials have been and are currently being conducted in the PBCC.
- Medicine and Medical Research